0001214659-21-003149.txt : 20210315 0001214659-21-003149.hdr.sgml : 20210315 20210315171035 ACCESSION NUMBER: 0001214659-21-003149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210311 FILED AS OF DATE: 20210315 DATE AS OF CHANGE: 20210315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taglietti Marco CENTRAL INDEX KEY: 0001408870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 21742377 MAIL ADDRESS: STREET 1: C/O FOREST LABORATORIES, INC. STREET 2: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 marketforms-51885.xml PRIMARY DOCUMENT X0306 4 2021-03-11 0001398733 Aquestive Therapeutics, Inc. AQST 0001408870 Taglietti Marco C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 true false false false Non-Qualified Stock Option (right to buy) 5.30 2021-03-11 4 A false 28500 0 A 2031-03-11 Common Stock 28500 28500 D The option vests in three equal annual installments beginning on March 11, 2022. /s/ Lori J. Braender, as Attorney-In-Fact 2021-03-15